PULLMAN, Wash. - Washington State University researcher Giuseppe Giannotti has received a $3 million grant from the National Institutes of Health to study how the brain drives drug cravings and relapse during opioid withdrawal, work that could lead to new treatments for opioid use disorder.
Giannotti, an assistant professor in the Department of Integrative Physiology and Neuroscience in WSU's College of Veterinary Medicine, will explore a region of the brain known as the paraventricular thalamus, which his laboratory and others have linked to withdrawal, drug-seeking behavior and cue-driven motivated behaviors. His team will use preclinical models to map how neurons in this region connect with other parts of the brain, with the goal of identifying cells that could be targeted by future therapies to interrupt the cycle of addiction.
"The goal is to understand the neural circuits that drive opioid use and relapse," Giannotti said. "If we can identify the circuits that fuel drug seeking during withdrawal, we may be able to develop new ways to interrupt that cycle. Once we know which circuits are responsible, we can begin developing approaches that could eventually be tested in patients."
The five-year award provides approximately $600,000 annually, totaling about $3 million.
One of the major challenges in treating opioid use disorder is relapse. While medications and behavioral therapies can help reduce opioid use and manage withdrawal symptoms, many people return to drug use after treatment.
"Addiction often follows a predictable cycle," Giannotti said. "A person takes a drug and experiences its rewarding effects. As those effects fade, they are left with a negative emotional state that motivates them to use again. With repeated use, this negative state intensifies and develops into withdrawal, a combination of physical symptoms, anxiety and strong cravings. Avoiding those symptoms then drives the person to seek the drug again, which perpetuates the cycle of addiction."
Preliminary data from Giannotti's laboratory at WSU suggest that distinct groups of neurons in the paraventricular thalamus become active during opioid withdrawal and may contribute to drug-seeking behavior triggered by drug-associated cues.
Giannotti will now build on that work by studying how these neurons respond to heroin-associated cues, how they communicate with the nucleus accumbens, a key reward region, and how they are influenced by dynorphin, a brain chemical released during stress and withdrawal.
"What I'm trying to understand with this grant is what in the brain actually drives people back to drug use," Giannotti said. "We're identifying the neurons that become active during withdrawal and determining how they drive drug-seeking behavior."
Ultimately, the research could identify neurons and neural circuits that may serve as targets for future therapies aimed at reducing cravings and preventing relapse.
"The idea is to understand the neural circuits that are driving the cycle of addiction," Giannotti said. "By learning which circuits are involved, we hope to eventually find ways to interrupt that cycle and target the neurons that drive drug-seeking behavior during withdrawal."